2026-04-13T02:58:22Zhttps://recercat.cat/oai/requestoai:recercat.cat:11351/121562025-10-24T10:36:43Zcom_2072_378070com_2072_378040col_2072_378092
2025-10-24T10:36:43Z
urn:hdl:11351/12156
Therapeutic strategies and treatment sequencing in patients with chronic lymphocytic leukemia: An international study of ERIC, the European Research Initiative on CLL
Minga, Eva
Chamou, Dimitra
Kotaskova, Jana
Chatzikonstantinou, Thomas
Scarfo', Lydia
KARAKATSOULIS, GEORGIOS
Bosch, Francesc
IACOBONI, GLORIA
Leucèmia limfocítica crònica - Tractament
Proteïnes quinases - Inhibidors - Ús terapèutic
CHEMICALS AND DRUGS::Enzymes and Coenzymes::Enzymes::Transferases::Phosphotransferases::Phosphotransferases (Alcohol Group Acceptor)::Protein Kinases::Protein-Tyrosine Kinases
Other subheadings::Other subheadings::Other subheadings::/antagonists & inhibitors
DISEASES::Neoplasms::Neoplasms by Histologic Type::Leukemia::Leukemia, Lymphoid::Leukemia, B-Cell::Leukemia, Lymphocytic, Chronic, B-Cell
Other subheadings::Other subheadings::Other subheadings::/drug therapy
COMPUESTOS QUÍMICOS Y DROGAS::enzimas y coenzimas::enzimas::transferasas::fosfotransferasas::fosfotransferasas (grupo alcohol aceptor)::proteína cinasas::proteína-tirosina cinasas
Otros calificadores::Otros calificadores::Otros calificadores::/antagonistas & inhibidores
ENFERMEDADES::neoplasias::neoplasias por tipo histológico::leucemia::leucemia linfoide::leucemia de células B::leucemia linfocítica crónica de células B
Otros calificadores::Otros calificadores::Otros calificadores::/farmacoterapia
Therapeutic strategies; Chronic lymphocytic leukemia
Estrategias terapéuticas; Leucemia linfocítica crónica
Estratègies terapèutiques; Leucèmia limfocítica crònica
This project was supported in part by AbbVie; AIRC under 5 per Mille 2018-ID. 21198 program (to PG and GG); PNRR-MAD-2022-12375673 (Next Generation EU, M6/C2_CALL 2022), Italian Ministry of Health, Rome, Italy, Conceptual development of research organization (FNBr 65269705) provided by the Ministry of Health of the Czech Republic, and National Institute for Cancer Research (Programme EXCELLES, ID Project No. LX22NPO5102) funded by the European Union—Next Generation EU.
2025-10-24T10:36:43Z
2025-10-24T10:36:43Z
2024-10-30T11:50:15Z
2024-10-30T11:50:15Z
2024-09-17
info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
http://hdl.handle.net/11351/12156
HemaSphere;8(9)
https://doi.org/10.1002/hem3.70004
Attribution-NonCommercial-NoDerivatives 4.0 International
http://creativecommons.org/licenses/by-nc-nd/4.0/
info:eu-repo/semantics/openAccess
Wiley
Scientia